Answer
Oct 01, 2025 - 05:53 AM
Nucala (mepolizumab) is a monoclonal antibody medication that targets and inhibits interleukin-5 (IL-5), a cytokine involved in the growth and activation of eosinophils, a type of white blood cell. By reducing eosinophil levels, Nucala helps manage severe eosinophilic asthma and other eosinophil-related conditions, decreasing inflammation and reducing the frequency of asthma attacks. It is administered via injection and is typically used as an add-on treatment for patients whose asthma is not well controlled with standard therapies.
